Dicerna more than doubles following IPO

After pricing its 6M-share IPO at $15, Dicerna Pharmaceuticals (DRNA) opened at $30 and is now trading at $31.90, up 113%.

The cancer/liver disease drug developer currently has a market cap of $530M.

Prospectus, IPO preview

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs